A Pilot SMART Design for Pathological Gamblers

Sponsor

UConn Health (Other)

Overall Status

Completed

CT.gov ID

NCT00685724

Collaborator

National Institute on Drug Abuse (NIDA) (NIH)

Enrollment

Location

Arms

37.9

Duration (Months)

1.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Pathological gambling is serious problem, with significant psychological, financial, and public health consequences. Nevertheless, controlled trials examining the efficacy of therapeutic interventions for pathological gamblers are sparse, and many pathological gamblers recover on their own, or with only minimal interventions. In this initial study of a SMART design for pathological gamblers, we will offer a brief intervention to all (n = 100), and subsequently randomize individuals based upon their initial treatment response to varying intensities of additional care from none to 8 sessions of individual cognitive behavioral therapy (CBT) plus 14 weeks of Aftercare. Gambling outcomes will be assessed pre-treatment and at about weeks 10, 24, 36 and 52.

Condition or Disease	Intervention/Treatment	Phase
Pathological Gambling	Behavioral: Motivational Enhancement Therapy (MET) Behavioral: Cognitive-Behavioral Therapy (CBT)	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

66 participants

Allocation:

Randomized

Intervention Model:

Factorial Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

A Pilot SMART Design for Pathological Gamblers

Study Start Date :

Jan 1, 2008

Actual Primary Completion Date :

Mar 1, 2011

Actual Study Completion Date :

Mar 1, 2011

Arms and Interventions

Arm	Intervention/Treatment
Experimental: 1 Following 2 sessions of MET intervention received by all patients, patients in Condition 1 receive no further intervention.	Behavioral: Motivational Enhancement Therapy (MET) MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
Experimental: 2 Patients in Condition 2 will receive 8 sessions of the CBT (Cognitive Behavioral Therapy) intervention.	Behavioral: Motivational Enhancement Therapy (MET) MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
Experimental: 3 Patients in Condition 3 will receive 8 sessions of CBT plus aftercare treatment.	Behavioral: Motivational Enhancement Therapy (MET) MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change. Behavioral: Cognitive-Behavioral Therapy (CBT) In CBT, clients learn to modify their thoughts as well as their behaviors by increasing awareness of the relationship between thoughts, emotions, and actions.

Arm

Intervention/Treatment

Experimental: 1

Following 2 sessions of MET intervention received by all patients, patients in Condition 1 receive no further intervention.

Behavioral: Motivational Enhancement Therapy (MET)

MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.

Experimental: 2

Patients in Condition 2 will receive 8 sessions of the CBT (Cognitive Behavioral Therapy) intervention.

Behavioral: Motivational Enhancement Therapy (MET)

MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.

Experimental: 3

Patients in Condition 3 will receive 8 sessions of CBT plus aftercare treatment.

Behavioral: Motivational Enhancement Therapy (MET)

MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.

Behavioral: Cognitive-Behavioral Therapy (CBT)

In CBT, clients learn to modify their thoughts as well as their behaviors by increasing awareness of the relationship between thoughts, emotions, and actions.

Outcome Measures

Primary Outcome Measures

self and collateral indices of gambling and gambling related problems [baseline and each follow-up]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

age > 18 years old, DSM-IV criteria for pathological gambling
2 gambling episodes in past 60 days
spent >$100 wagering in the past 60 days
willingness to accept random assignment after the brief intervention.

Exclusion Criteria:

Reading level below 5th grade
uncontrolled psychiatric conditions (e.g., active suicidal intention, psychosis, bipolar disorder)

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Connecticut Health Center	Farmington	Connecticut	United States	06030

Sponsors and Collaborators

UConn Health
National Institute on Drug Abuse (NIDA)

Investigators

Principal Investigator: Nancy M Petry, Ph.D., UConn Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

UConn Health

ClinicalTrials.gov Identifier:

NCT00685724

Other Study ID Numbers:

07-259
P50DA009241

First Posted:

May 28, 2008

Last Update Posted:

Apr 9, 2019

Last Verified:

Apr 1, 2019

Keywords provided by UConn Health

pathological gambling

cognitive-behavioral therapy

motivational enhancement therapy

Additional relevant MeSH terms:

Gambling

Study Results

No Results Posted as of Apr 9, 2019